@newsramp.comBiotech leader Philip Ashton-Rickardt says the best scientists know when to change course. 'Flexibility is not failure. Sometimes it means you learned something.' A mindset worth adopting across all of R&D. #Biotech #Leadership
@dominic-tyer.bsky.socialModerna outlined its COVID-era manufacturing lessons and how the biotech works with CDMOs at CPHI Milan this week
@pharmalot.bsky.socialUp and Down the Ladder: Job Changes.. the latest comings and goings.. statnews.com/pharmalot/20... #pharma #biotech #jobs #Genentech #Novartis #BioMarin #Roche
@insiderdashboard.bsky.social🔥 Top 10 BIOTECH Leadership Stocks! MRNA (+408.3%), QURE (+109.3%), ILMN (+59.9%) leading the charge with impressive YTD returns. #BIOTECH #LeadershipStocks #Investing
@discoveripo.bsky.socialCITY THERAPEUTICS, INC. filed for an IPO
City Therapeutics, Inc., a biotech firm focused on RNAi therapeutics, has filed for an IPO. The company aims to address unmet medical needs.
Biotech
#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #RNAinterference
@quartzmedia.bsky.social
@byteandpieces.bsky.social📣 New Podcast! "The Accidental Anti-Aging Drug: How AI Is Changing Everything" on @Spreaker #ai #antiaging #biohacking #biotech #biotechnology #clinicaltrials #drugdiscovery #futureofmedicine #futuretech #genetics #healthspan #healthtech #innovation #insilicomedicine #longevity #medicine
@drtimos.bsky.socialSignal or noise? > Prula-cel Shows Early Promise in Lupus - The Medicine
Maker >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #healthcare #biotech #pharmaceutical
@fediboard-mix.bsky.social
@4040rec.bsky.social
@biotechstockdaily.bsky.socialMarvel Biosciences signs a CRO letter of intent for the planned first human trial of MB-204 in Australia.
#Biotech #Biotechnology #Trial #Australia
Disclaimer: This is NOT a financial advice
@discoveripo.bsky.socialnews reports say Iambic Therapeutics, Inc. is expected to list on October 15, 2026
News reports indicate that Iambic Therapeutics, Inc. is expected to list on October 15, 2026. This biotech firm focuses on enhancing drug…
Biotech
#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews
@artificialscience.bsky.socialAI-designed enzymes can now dismantle PET plastic in hours. Why is industry still waiting? The evidence, explained. #PlasticWaste #AI #Biotech #CircularEconomy
@thedailyfathom.bsky.socialBIOTECH · Argenx halts Vyvgart trial in Sjögren's, shares fall 14%
The biotech stopped a late-stage study after an independent panel found the drug unlikely to beat a placebo, erasing a hoped-for expansion.
@newsramp.comGeoVax (GOVX) is appealing a Nasdaq delisting notice with a hearing set for Oct. 13, 2026, while pushing ahead on its mpox vaccine GEO-MVA toward Phase 3 trials and its oncology program Gedeptin. Strategic priorities remain firmly on track. #Biotech #Biodefense
@newsramp.comSeven life sciences companies present live on Sept. 17 at the B2i Digital Virtual Investor Forum — covering oncology, antibiotics, drug delivery, cannabinoid therapeutics & more. Live Q&A included, replays on demand. #LifeSciences #Biotech
@drtimos.bsky.socialSignal or noise? > Reusing data could cut R&D costs and greatly
increase gene editing’s reach: ARM - BioSpace >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #pharma #competitivemarketing
@newsramp.comTelomir Pharmaceuticals reports Telomir-Zn inhibited growth in human and canine osteosarcoma models at Ohio State University, supporting a potential translational development pathway. The company also advances its FDA-cleared TNBC Phase 1/2 program. #Oncology #Biotech
@newsramp.comQuantum BioPharma (NASDAQ: QNTM) receives FDA clearance for its Lucid-MS IND application, paving the way for a Phase 2 trial targeting myelin degradation in multiple sclerosis patients. A major milestone for this micro-cap biotech. #Biotech #MultipleSclerosis
@newsramp.comRegentis Biomaterials (RGNT) is advancing GelrinC, a hydrogel implant designed to regenerate knee cartilage. Already approved in Europe, an FDA-authorized pivotal trial is now underway for potential U.S. approval. #Biotech #MedTech